{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T21:56:38Z","timestamp":1778104598747,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Zhejiang Traditional Chinese Medicine science and technology project","award":["2023ZL150"],"award-info":[{"award-number":["2023ZL150"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00228-025-03895-7","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T17:19:01Z","timestamp":1753723141000},"page":"1473-1479","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Study on disproportionality in the detection of potential signals between quetiapine and diabetic ketoacidosis"],"prefix":"10.1007","volume":"81","author":[{"given":"Haiya","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongjing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"issue":"7578","key":"3895_CR1","doi-asserted-by":"publisher","first-page":"S172","DOI":"10.1038\/nature16032","volume":"527","author":"F Baingana","year":"2015","unstructured":"Baingana F et al (2015) Global research challenges and opportunities for mental health and substance-use disorders. Nature 527(7578):S172\u2013S177. https:\/\/doi.org\/10.1038\/nature16032","journal-title":"Nature"},{"issue":"6","key":"3895_CR2","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1017\/S1461145712001277","volume":"16","author":"JP Zhang","year":"2013","unstructured":"Zhang JP et al (2013) Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis. Int J Neuropsychopharmacol 16(6):1205\u201318. https:\/\/doi.org\/10.1017\/S1461145712001277","journal-title":"Int J Neuropsychopharmacol"},{"issue":"Suppl 2","key":"3895_CR3","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/S0924-9338(10)71701-6","volume":"25","author":"CU Correll","year":"2010","unstructured":"Correll CU (2010) From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics. Eur Psychiatry 25(Suppl 2):S12-21. https:\/\/doi.org\/10.1016\/S0924-9338(10)71701-6","journal-title":"Eur Psychiatry"},{"issue":"8","key":"3895_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3928\/02793695-20130709-01","volume":"51","author":"AC Carney","year":"2013","unstructured":"Carney AC (2013) Efficacy of quetiapine off-label uses: data synthesis. J Psychosoc Nurs Ment Health Serv 51(8):11\u201318. https:\/\/doi.org\/10.3928\/02793695-20130709-01","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"key":"3895_CR5","unstructured":"in Bipolar Disorder: The NICE Guideline on the Assessment and Management of Bipolar Disorder in Adults, Children and Young People in Primary and Secondary Care. 2014: London"},{"issue":"2","key":"3895_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/bdi.12609","volume":"20","author":"LN Yatham","year":"2018","unstructured":"Yatham LN et al (2018) Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord 20(2):97\u2013170. https:\/\/doi.org\/10.1111\/bdi.12609","journal-title":"Bipolar Disord"},{"issue":"8","key":"3895_CR7","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/bdi.12959","volume":"22","author":"H Sakurai","year":"2020","unstructured":"Sakurai H et al (2020) Pharmacological management of bipolar disorder: Japanese expert consensus. Bipolar Disord 22(8):822\u2013830. https:\/\/doi.org\/10.1111\/bdi.12959","journal-title":"Bipolar Disord"},{"key":"3895_CR8","doi-asserted-by":"publisher","unstructured":"Wang Z et al., (2023) Efficacy of Quetiapine Monotherapy and Combination Therapy for Patients with Bipolar Depression with Mixed Features: A Randomized Controlled Pilot Study. Pharmaceuticals (Basel), 16(2). https:\/\/doi.org\/10.3390\/ph16020287","DOI":"10.3390\/ph16020287"},{"key":"3895_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.euroneuro.2022.11.008","volume":"67","author":"CY Lin","year":"2023","unstructured":"Lin CY et al (2023) Effects of quetiapine on sleep: A systematic review and meta-analysis of clinical trials. Eur Neuropsychopharmacol 67:22\u201336. https:\/\/doi.org\/10.1016\/j.euroneuro.2022.11.008","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"3895_CR10","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/s12888-021-03374-0","volume":"21","author":"J Wang","year":"2021","unstructured":"Wang J et al (2021) Off-label use of antipsychotic medications in psychiatric inpatients in China: a national real-world survey. BMC Psychiatry 21(1):375. https:\/\/doi.org\/10.1186\/s12888-021-03374-0","journal-title":"BMC Psychiatry"},{"issue":"2","key":"3895_CR11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nrendo.2011.156","volume":"8","author":"M De Hert","year":"2011","unstructured":"De Hert M et al (2011) Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol 8(2):114\u2013126. https:\/\/doi.org\/10.1038\/nrendo.2011.156","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"3895_CR12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMoa0806994","volume":"360","author":"WA Ray","year":"2009","unstructured":"Ray WA et al (2009) Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 360(3):225\u2013235. https:\/\/doi.org\/10.1056\/NEJMoa0806994","journal-title":"N Engl J Med"},{"key":"3895_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jad.2017.09.020","volume":"226","author":"CS Wu","year":"2018","unstructured":"Wu CS et al (2018) Psychotropic use and risk of stroke among patients with bipolar disorders: 10-year nationwide population based study. J Affect Disord 226:77\u201384. https:\/\/doi.org\/10.1016\/j.jad.2017.09.020","journal-title":"J Affect Disord"},{"key":"3895_CR14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jpsychires.2021.11.023","volume":"149","author":"J Berge","year":"2022","unstructured":"Berge J et al (2022) Associations between off-label low-dose olanzapine or quetiapine and cardiometabolic mortality. J Psychiatr Res 149:352\u2013358. https:\/\/doi.org\/10.1016\/j.jpsychires.2021.11.023","journal-title":"J Psychiatr Res"},{"issue":"2","key":"3895_CR15","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/acps.12439","volume":"132","author":"B Stubbs","year":"2015","unstructured":"Stubbs B et al (2015) The prevalence and predictors of type two diabetes mellitus in people with schizophrenia: a systematic review and comparative meta-analysis. Acta Psychiatr Scand 132(2):144\u2013157. https:\/\/doi.org\/10.1111\/acps.12439","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"3895_CR16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1192\/bjp.bp.109.067512","volume":"196","author":"S Brown","year":"2010","unstructured":"Brown S et al (2010) Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry 196(2):116\u2013121. https:\/\/doi.org\/10.1192\/bjp.bp.109.067512","journal-title":"Br J Psychiatry"},{"issue":"2","key":"3895_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2165\/00024677-200302020-00003","volume":"2","author":"GE Umpierrez","year":"2003","unstructured":"Umpierrez GE, Kitabchi AE (2003) Diabetic ketoacidosis: risk factors and management strategies. Treat Endocrinol 2(2):95\u2013108","journal-title":"Treat Endocrinol"},{"issue":"11","key":"3895_CR18","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/dme.14109","volume":"36","author":"CJ Garrett","year":"2019","unstructured":"Garrett CJ et al (2019) Recurrent diabetic ketoacidosis and a brief history of brittle diabetes research: contemporary and past evidence in diabetic ketoacidosis research including mortality, mental health and prevention. Diabet Med 36(11):1329\u20131335","journal-title":"Diabet Med"},{"issue":"943","key":"3895_CR19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/dme.14109","volume":"80","author":"P English","year":"2004","unstructured":"English P, Williams G (2004) Hyperglycaemic crises and lactic acidosis in diabetes mellitus. Postgrad Med J 80(943):253\u2013261. https:\/\/doi.org\/10.1111\/dme.14109","journal-title":"Postgrad Med J"},{"issue":"7","key":"3895_CR20","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7150\/ijms.6048","volume":"10","author":"T Sakaeda","year":"2013","unstructured":"Sakaeda T et al (2013) Data mining of the public version of the FDA Adverse Event Reporting System. Int J Med Sci 10(7):796\u2013803. https:\/\/doi.org\/10.7150\/ijms.6048","journal-title":"Int J Med Sci"},{"key":"3895_CR21","doi-asserted-by":"publisher","unstructured":"Wang, X., H. Yang, and Z. An, (2024) Tacrolimus related diabetic ketoacidosis and hyperglycaemic hyperosmolar nonketotic syndrome: an observational, retrospective, pharmacovigilance study. Expert Opin Drug Saf, 1\u20136. https:\/\/doi.org\/10.1080\/14740338.2024.2393278.","DOI":"10.1080\/14740338.2024.2393278"},{"issue":"8","key":"3895_CR22","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1001\/jama.2017.20834","volume":"319","author":"AL Sennesael","year":"2018","unstructured":"Sennesael AL, Henrard S, Spinewine A (2018) Drug Interactions With Non-Vitamin K Oral Anticoagulants. JAMA 319(8):829. https:\/\/doi.org\/10.1001\/jama.2017.20834","journal-title":"JAMA"},{"issue":"10360","key":"3895_CR23","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A et al (2022) Hepatocellular carcinoma. Lancet 400(10360):1345\u20131362","journal-title":"Lancet"},{"issue":"1","key":"3895_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/pds.668","volume":"11","author":"EP van Puijenbroek","year":"2002","unstructured":"van Puijenbroek EP et al (2002) A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf 11(1):3\u201310. https:\/\/doi.org\/10.1002\/pds.668","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"3895_CR25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1046\/j.1365-2125.2003.01968.x","volume":"57","author":"AM Wilson","year":"2004","unstructured":"Wilson AM, Thabane L, Holbrook A (2004) Application of data mining techniques in pharmacovigilance. Br J Clin Pharmacol 57(2):127\u2013134. https:\/\/doi.org\/10.1046\/j.1365-2125.2003.01968.x","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"3895_CR26","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds.677","volume":"10","author":"SJ Evans","year":"2001","unstructured":"Evans SJ, Waller PC, Davis S (2001) Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 10(6):483\u2013486. https:\/\/doi.org\/10.1002\/pds.677","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"3895_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2165\/00002018-200326030-00003","volume":"26","author":"M Hauben","year":"2003","unstructured":"Hauben M, Zhou X (2003) Quantitative methods in pharmacovigilance: focus on signal detection. Drug Saf 26(3):159\u2013186. https:\/\/doi.org\/10.2165\/00002018-200326030-00003","journal-title":"Drug Saf"},{"issue":"6","key":"3895_CR28","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s11096-022-01472-x","volume":"44","author":"JJ Chen","year":"2022","unstructured":"Chen JJ et al (2022) Data mining for adverse drug reaction signals of daptomycin based on real-world data: a disproportionality analysis of the US Food and Drug Administration adverse event reporting system. Int J Clin Pharm 44(6):1351\u20131360. https:\/\/doi.org\/10.1007\/s11096-022-01472-x","journal-title":"Int J Clin Pharm"},{"issue":"12","key":"3895_CR29","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1080\/15563650.2019.1677022","volume":"57","author":"DD Gummin","year":"2019","unstructured":"Gummin DD et al (2019) 2018 Annual Report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 36th Annual Report. Clin Toxicol (Phila) 57(12):1220\u20131413. https:\/\/doi.org\/10.1080\/15563650.2019.1677022","journal-title":"Clin Toxicol (Phila)"},{"issue":"08","key":"3895_CR30","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.7539\/j.issn.1672-2981.2024.08.048","volume":"22","author":"ZZ Deng","year":"2024","unstructured":"Deng ZZ et al (2024) Data mining of adverse drug enent signals for quetiapine based on FAERS database. Central South Pharmacy 22(08):2248\u20132254. https:\/\/doi.org\/10.7539\/j.issn.1672-2981.2024.08.048","journal-title":"Central South Pharmacy"},{"issue":"7","key":"3895_CR31","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.2337\/dc09-9032","volume":"32","author":"AE Kitabchi","year":"2009","unstructured":"Kitabchi AE et al (2009) Hyperglycemic crises in adult patients with diabetes. Diabetes Care 32(7):1335\u20131343. https:\/\/doi.org\/10.2337\/dc09-9032","journal-title":"Diabetes Care"},{"issue":"3","key":"3895_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2022.101418","volume":"69","author":"APP Calimag","year":"2023","unstructured":"Calimag APP et al (2023) Diabetic ketoacidosis. Dis Mon 69(3):101418. https:\/\/doi.org\/10.1016\/j.disamonth.2022.101418","journal-title":"Dis Mon"},{"issue":"8","key":"3895_CR33","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2337\/dc17-1379","volume":"41","author":"D Desai","year":"2018","unstructured":"Desai D et al (2018) Health Care Utilization and Burden of Diabetic Ketoacidosis in the U.S. Over the Past Decade: A Nationwide Analysis. Diabetes Care 41(8):1631\u20131638. https:\/\/doi.org\/10.2337\/dc17-1379","journal-title":"Diabetes Care"},{"issue":"1","key":"3895_CR34","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1399-5448.2010.00728.x","volume":"12","author":"M Fritsch","year":"2011","unstructured":"Fritsch M et al (2011) Predictors of diabetic ketoacidosis in children and adolescents with type 1 diabetes. Experience from a large multicentre database. Pediatr Diabetes 12(1):307\u201312. https:\/\/doi.org\/10.1111\/j.1399-5448.2010.00728.x","journal-title":"Pediatr Diabetes"},{"key":"3895_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d4092","volume":"343","author":"JA Usher-Smith","year":"2011","unstructured":"Usher-Smith JA et al (2011) Factors associated with the presence of diabetic ketoacidosis at diagnosis of diabetes in children and young adults: a systematic review. BMJ 343:d4092. https:\/\/doi.org\/10.1136\/bmj.d4092","journal-title":"BMJ"},{"issue":"11","key":"3895_CR36","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.2337\/dc18-0657","volume":"41","author":"K Goueslard","year":"2018","unstructured":"Goueslard K et al (2018) Increased Risk of Rehospitalization for Acute Diabetes Complications and Suicide Attempts in Patients With Type 1 Diabetes and Comorbid Schizophrenia. Diabetes Care 41(11):2316\u20132321. https:\/\/doi.org\/10.2337\/dc18-0657","journal-title":"Diabetes Care"},{"issue":"6","key":"3895_CR37","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.2337\/dc13-1867","volume":"37","author":"PM Trief","year":"2014","unstructured":"Trief PM et al (2014) Depression in adults in the T1D Exchange Clinic Registry. Diabetes Care 37(6):1563\u20131572. https:\/\/doi.org\/10.2337\/dc13-1867","journal-title":"Diabetes Care"},{"issue":"2","key":"3895_CR38","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1089\/jwh.2012.3972","volume":"23","author":"M Manteuffel","year":"2014","unstructured":"Manteuffel M et al (2014) Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines. J Womens Health (Larchmt) 23(2):112\u2013119. https:\/\/doi.org\/10.1089\/jwh.2012.3972","journal-title":"J Womens Health (Larchmt)"},{"key":"3895_CR39","doi-asserted-by":"publisher","unstructured":"Geerlings SE. (2016) Clinical Presentations and Epidemiology of Urinary Tract Infections. Microbiol Spectr. 4(5). https:\/\/doi.org\/10.1128\/microbiolspec.UTI-0002-2012","DOI":"10.1128\/microbiolspec.UTI-0002-2012"},{"issue":"9","key":"3895_CR40","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/s0002-9343(01)01000-2","volume":"111","author":"E Koller","year":"2001","unstructured":"Koller E et al (2001) Clozapine-associated diabetes. Am J Med 111(9):716\u2013723. https:\/\/doi.org\/10.1016\/s0002-9343(01)01000-2","journal-title":"Am J Med"},{"issue":"6","key":"3895_CR41","doi-asserted-by":"publisher","first-page":"857","DOI":"10.4088\/jcp.v65n0619","volume":"65","author":"EA Koller","year":"2004","unstructured":"Koller EA et al (2004) A survey of reports of quetiapine-associated hyperglycemia and diabetes mellitus. J Clin Psychiatry 65(6):857\u2013863. https:\/\/doi.org\/10.4088\/jcp.v65n0619","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"3895_CR42","doi-asserted-by":"publisher","first-page":"533","DOI":"10.4088\/jcp.v68n0407","volume":"68","author":"DC Henderson","year":"2007","unstructured":"Henderson DC et al (2007) Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics. J Clin Psychiatry 68(4):533\u2013541. https:\/\/doi.org\/10.4088\/jcp.v68n0407","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"3895_CR43","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1176\/appi.ajp.161.9.1709","volume":"161","author":"DL Leslie","year":"2004","unstructured":"Leslie DL, Rosenheck RA (2004) Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications. Am J Psychiatry 161(9):1709\u20131711. https:\/\/doi.org\/10.1176\/appi.ajp.161.9.1709","journal-title":"Am J Psychiatry"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-025-03895-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-025-03895-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-025-03895-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T06:37:07Z","timestamp":1758091027000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-025-03895-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["3895"],"URL":"https:\/\/doi.org\/10.1007\/s00228-025-03895-7","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The FAERS database is public and contains anonymous patient information. The Hospital Ethics Committee has confirmed that ethics approval is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}